A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas

Although checkpoint inhibitors have been approved in multiple cancers, they are still under investigation in soft tissue sarcoma (STS). We conducted a retrospective review to report the safety, efficacy, and prognostic factors related to checkpoint inhibitors in STS. A sequential cohort of metastati...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2020-07, Vol.12 (7), p.1873
Hauptverfasser:	Monga, Varun, Skubitz, Keith M, Maliske, Seth, Mott, Sarah L, Dietz, Hilary, Hirbe, Angela C, Van Tine, Brian A, Oppelt, Peter, Okuno, Scott, Robinson, Steven, O'Connor, Madeline, Seetharam, Mahesh, Attia, Steven, Charlson, John, Agulnik, Mark, Milhem, Mohammed
Format:	Artikel
Sprache:	eng
Schlagworte:	Alveoli Bone cancer Chemotherapy Clinical trials Disease Fibrosarcoma Immune checkpoint Immunotherapy Liposarcoma Medical prognosis Metastases Metastasis Monoclonal antibodies Patients PD-1 protein Pembrolizumab Regression analysis Response rates Sarcoma Soft tissue sarcoma Studies Survival Targeted cancer therapy Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!